See also this year's filing and all EDGAR filings for this company.
PDF Report 0001552189_2020_Panacea_LIFE_Sciences_Holdings_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 12625936, 'size_variable': 'Assets', 'size_value': 71268, 'ratio': 177.2, 'threshold': 20} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001552189')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('stock_price')"} |
Graph
Absolute values for 0001552189, Panacea LIFE Sciences Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 1,926,887 |
| 1 | LiabilitiesCurrent | 4,190,544 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 2,429,235 |
| 4 | AssetsNoncurrent | 2,173,253 |
| 5 | PropertyPlantAndEquipmentNet | 477,433 |
| 6 | Goodwill | 2,147,311 |
| 7 | remainder_Assets | 2,572,045 |
| 8 | GeneralAndAdministrativeExpense | 6,266,628 |
| 9 | ResearchAndDevelopmentExpense | 22,100 |
| 10 | remainder_Expenses | 4,935,394 |
| 11 | remainder_Revenues | 345,680 |
| 12 | remainder_NetIncome | 653,936 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 6,117,431 |
| 1 | Assets | 9,799,277 |
| 2 | Expenses | 11,224,122 |
| 3 | Revenues | 345,680 |
| 4 | StockholdersEquity | 3,681,846 |
| 5 | NetIncome | -10,224,506 |
| 6 | ComprehensiveNetIncome | -10,224,506 |
| 7 | BaseVar | 14,070,223 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.651 |
| 9 | EconomicCapitalRatio | 0.770 |
Edgar->Model Mapping
Feature Distribution
Change over Time
